Merck The Fda And Vioxx Essay

1721 words - 7 pages

Due: 8/4/14
Merck, the FDA, and Vioxx

Summary of Facts –
* Merck gave patent of streptomycin to a university foundation.
* Merck’s core values are said to be: medicine is for the people and not for profits.
* In 2000, Merck spent $3 billion annually on research.
* September 30th, 2004, Merck recalled Vioxx as it doubled the risk of heart attack and stroke for users.
* The recall decision was expected to cost Merck $2.5 billion in revenues as it was their second largest selling drug.
* Vioxx was the fastest selling drug in Merck’s product portfolio.
* Merck disagreed with all the reports until their own internal study (APPROVe) suggested cardiovascular risks ...view middle of the document...

Patients on high dosage of Vioxx, had three times the rate of heart attacks than those patients on Celebrex. This lead to Merck discounting this finding saying the studies were less reliable than double blind clinical studies.

Responses to questions –

1. Do you believe Merck acted in a socially responsible and ethical manner with regard to Vioxx? Address the company’s drug development and testing, marketing, advertising, relationships with government and policymakers, and handling of the recall.

In regards to whether Merck acted in a socially responsible or ethical manner is difficult to determine without covering every bit of information presented. A case could be made that the Prescription Drug Free User Act (PDUFA) could have led to an increase in prescription drugs being looked at with less scrutiny. As shown, after Congress granted the Food and Drug Administration the authority to begin charging a mandatory “user fee” in order to review new proposed medicines; this allowed the FDA to shorten the approval time for new drugs from 27 months in 1993 to 14 months in 2001, nearly cutting the time in half. Was it socially responsible or ethical to grant to FDA the authority to begin collecting mandatory revenue for new medicines? An argument has and could be made to the contrary as stated in an article published in the Journal of the American Medical Association (JAMA) in December of 2004 stated, “It is unreasonable to expect that the same agency that was responsible for the approval of drug licensing and labeling would also be committed to actively seek evidence to prove itself wrong (i.e., that the decision to approve the product was subsequently shown to be incorrect)”. During the development process, there is evidence to suggest that Merck was aware of the risks involved relating to cardiac episodes in patients. With the VIGOR test conducted internally to compare the risks of cardiac episodes in patients taking Vioxx and others taking Aleve, the results showed a clear 7.3 per thousand person-years in Vioxx to 1.7 per thousand person-years. After the evidence of the VIGOR test, Merck conducted a similar test dubbed APPROVe in which enrolled patients were studied to determine the likelihood of patients suffering from a heart attack or stroke while on Vioxx as opposed to taking a placebo. After 18 months of study, it was shown that patients taking Vioxx we twice as likely to suffer from a heart attack or stroke as opposed to those taking the placebo. What is most alarming is that both of these studies were conducted after Vioxx was released to the general public.

Speculation can be made as to the intended purpose of pharmaceutical companies establishing stealth PAC’s in order to make anonymous political donations. Given that Merck spent $40.7 million on lobbying between 1998 and 2004 is interesting to note, however, Merck ultimately made the decision to recall Vioxx in 2004 after extensive studies and research determining...

Other Essays Like Merck the Fda and Vioxx

Investment Portfoli Essay

3598 words - 15 pages complies with all applicable laws and regulations. As a matter of fact, Merck was being faced by lawsuits from people who suffered heart attacks while taking Vioxx even prior to the withdrawal and several sources of public data had been flagging the risk of heart attack by the medicine, which is implying based on EMH theory that the share price even before the announcement was reflecting the risk by the public information exposed to investors in

Case Questions Essay

974 words - 4 pages Questions 1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drug? 2. Build a decision tree that shows the cash flows and probabilities at all stages of the FDA approval process. 3. Should Merck bid to license Davanrik? How much should they pay? 4. What is the expected value of the licensing arrangement to LAB? Assume a 5% royalty fee on any cash flows that Merck receives from Davanrik

Merck & Company -Evaluating a Drug Licensing Opportunity .Doc

1148 words - 5 pages INTRODUCTION Merck & Company : Evaluating the Licensing Opportunity Various recently-born biotech companies sell their technologies in either finished or early stage to bigger companies in need of financing capital to preceed business, while those bigger companies acquire technologies to scout for promising profitable business. This sort of process needs numbers of decision makings and agreements from both parties on the valuation methods

Case Study

701 words - 3 pages a day on which the restaurant was always closed), and notified employees that the preceding day had been their last day of employment for the restaurant. Employees who wanted to continue to work for the restaurant were asked to assist in a one-day packing workday, after which they would be let go permanently. II. Internet Exercise www.merck.comSixty years ago, the first package of brown powder called Penicillin left the Merck Lab for a

Merk & Co Case (A) Study

1050 words - 5 pages problematic from a logistics, economic and socio-political point of view (e.g. corruption and third world government favoritism). Arguments for investing are supported by the ideal oriented research center and the rest of the stakeholders and include: MERCK's corporate philosophy is based on virtuous ethics: "Medicine is for the people and profits will follow"; The value proposition used to attract the "best and the brightest&quot

Core Functions of Fda

2723 words - 11 pages Thesis: One of the biggest agencies within the U.S. Department of Health and Human Services is the Food and Drug Administration (FDA). The Office of the Commissioner and four directorates administer the core functions of the agency which are medical products and tobacco, foods and veterinary medicine, global regulatory operations and policy, and operations. While being a huge, big named agency designed to protect and provide public health

Dick Butkus

698 words - 3 pages and Drug Administration The U.S. Food and Drug Administration (FDA) was formed in 1906. The FDA is an agency of the United States Department of Health and Human Services. It is responsible for safety regulations for most foods, dietary supplements, legal drugs, vaccines, biological medical products, medical devices, veterinary products, cosmetics, radiation-emitting devices, and blood products. They are also responsible for sanitation

Dr Reddys Company Profile

3470 words - 14 pages the advantage of not having to spend time and money on a manufacturing plant that that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This

Grass Pollen Allergy Global Clinical Trials Review, H2, 2014 Markt Research Report Share

1718 words - 7 pages Grass Pollen Allergy Global Clinical Trials Review, H2, 2014 Grass Pollen Allergy Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, Grass Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Grass Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Grass Pollen Allergy. It includes an overview of the trial numbers

Role and Functions of Law

923 words - 4 pages day professional life, both, positively and negatively. Through the strict governance and regulating of the Federal Drug Administration (FDA), Roxane Labs are able to supply society with high quality and safe drugs. Law in Society. Law plays a significant role in producing successful societal functions around the world. Law helps regulate social behaviors, ultimately leading to society running efficiently. Without laws, society would have no


548 words - 3 pages that the concentrate was adulterated. Even worse, they didn’t stop illegally selling the apple juice, even after third party inspections by the FDA and PAI. What they chose to do was to take advantages of loopholes in the law. In order to avoid seizure by FDA, phony juice were transferred from one warehouse to another, to foreign countries and overseas markets so that Beech-Nut was able to minimize its financial losses and get rid of legal

Related Papers

Merck, The Fda, And The Vioxx Recall

1166 words - 5 pages people they helped or cured. The pharmaceutical giant Merck that manufactured Vioxx was ranked number three of the world’s top pharmaceutical companies with sales of $30.78 billion dollars and profits of $7.8 billion. In the eight-page letter, the FDA says Merck engaged "in a promotional campaign for Vioxx that minimizes the potentially serious cardiovascular findings that were observed" in a clinical trial comparing Vioxx to naproxen, a less

Merck And Company: Vioxx Essay

571 words - 3 pages Merck and Company recently pulled its arthritis medication, Vioxx, off the shelves because of recent studies that link the drug to increased risk of heart attack and stroke. The FDA had been conducting a study that showed an increased amount of cardiovascular problems in those who had been using Vioxx for eighteen months or more. This decision has outraged many Vioxx users because many had no idea of the newfound risks associated with Vioxx

Vioxx Decisions Essay

1341 words - 6 pages Food and Drug Administration (FDA) in May 2009 (Cavusgil, 2007). Vioxx became one of the top five selling drugs in the market in the next five years. However, Merck pulled the drug from the market on September 30, 2004 due to increased observations of cardiac arrest and stroke in many consumers. Merck faced an ethical dilemma when it found increased observations of cardiovascular problems in patients. However, it took many years for the company

Merk Annual Report

1389 words - 6 pages [pic] Jenna Christadore Annual Report Professor John Mecchia DEAR SHAREHOLDERS: More innovative. More customer-focused. Leaner and more agile. These are the defining characteristics of the new Merck we are continuing to build. This past year has underscored the importance of our ongoing work to emerge as a leader in the pharmaceutical industry of the future. It has also both tested — and proven